# Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer

> **NCT06358625** · — · RECRUITING · sponsor: **Center Eugene Marquis** · enrollment: 120 (estimated)

## Conditions studied

- HER2-positive Breast Cancer

## Interventions

- **OTHER:** Pre-treatment biopsy

## Key facts

- **NCT ID:** NCT06358625
- **Lead sponsor:** Center Eugene Marquis
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-06
- **Primary completion:** 2031-06-06
- **Final completion:** 2031-06-06
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06358625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06358625, "Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06358625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*